Results 11 to 20 of about 55,966 (208)

Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT. [PDF]

open access: yesPLoS ONE, 2018
To investigate the value of spectral CT in the differential diagnosis of benign from malignant pleural effusion.14 patients with benign pleural effusion and 15 patients with malignant pleural effusion underwent non-contrast spectral CT imaging.
Xirong Zhang   +7 more
doaj   +1 more source

C-reactive protein and serum amyloid A levels in discriminating malignant from non-malignant pleural effusion

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2015
Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different ...
Hala Mohamed Shalaby Samaha   +3 more
doaj   +1 more source

A clinical study of pleural effusion and its radiological, biochemical, bacteriological and cytological correlation

open access: yesJournal of Integrated Health Sciences, 2017
Introduction: Pleural effusion refers to excessive or abnormal accumulation of fluid in the pleural space. It is a commonly encountered medical problem caused by a variety of underlying pathological conditions.
N D Khamar   +3 more
doaj   +1 more source

New biomarkers for the diagnosis of pleural effusion

open access: yesThe Egyptian Journal of Bronchology, 2022
Background Persistent undiagnosed effusion is present in approximately 15% of all causes of exudative effusion. Pleural effusion caused by immunoglobulin G4 (IgG4) is a new type of pleural effusion.
Raafat T. El-Sokkary   +3 more
doaj   +1 more source

Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions

open access: yesClinics, 2014
OBJECTIVES: Our previous study demonstrated that superoxide dismutase levels were higher in tuberculous pleural effusions than in malignant pleural effusions, but that this difference ...
Maoshui Wang   +2 more
doaj   +1 more source

Management of malignant pleural effusions

open access: yesCurrent Opinion in Pulmonary Medicine, 2020
Purpose of review Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options.
Dipper, Alexandra   +2 more
openaire   +5 more sources

Value of Detection of CAIX in the Pleural Effusion and Its Sediment in the Diagnosis of Lung Cancer

open access: yesChinese Journal of Lung Cancer, 2015
Background and objective Carbonic anhydrase IX (CAIX) is widely expressed in a variety of malignant tumors, including-lung cancer. Our previous study has shown that the serum level of soluble form of carbonic anhydrase IX (s-CAIX) was significantly ...
Lina PENG   +4 more
doaj   +1 more source

Recurrence of malignant melanoma presenting as black-colored pyopneumothorax: a rare entity

open access: yesAnnals of Saudi Medicine, 2017
We report a 63-year-old patient with black-colored pus (pyopneumothorax) resulting from an infected pleural effusion associated with metastatic malignant melanoma of the skin.
Ganesh Patel   +4 more
doaj   +1 more source

The role of tumor necrosis factor alpha in differentiation between malignant and non malignant pleural effusion

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2016
Background: Despite the fact that Light’s criteria remain the gold standard approach in differentiating exudates from transudates, several fluid markers have been introduced for establishing the cause of pleural effusion to differentiate types of pleural
Heba M. Atef   +3 more
doaj   +1 more source

Different Therapeutic Strategies in 2 Young Patients with Advanced ALK-Rearranged Lung Adenocarcinoma: “The Light at the End of the Tunnel”

open access: yesCase Reports in Oncology, 2021
Malignant pleural effusion represents a prognostic negative factor on survival conferring stage IV disease. The median of survival is 5 months and a 5-year survival of about 3%.
Umberto Caterino   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy